Protagonist Therapeutics PTGX
NASDAQ PTGX
$138.43 -1.10 (-0.79%)
At close: Oct 23, 2026 · 4:00 PM EDT

Protagonist Therapeutics (PTGX) Cash & Current Investments (2015 - 2026)

Updated

Protagonist Therapeutics' Cash & Current Investments came in at $782.58 million for Q2 2026, up 37.2% from $570.47 million a year earlier and up 42.9% from the prior quarter.

Analysis

Protagonist Therapeutics (PTGX) Cash & Current Investments (2015 - 2026) Analysis & Trends

At the end of FY2025, Protagonist Therapeutics' Cash & Current Investments was $567.39 million, up 35.4% from FY2024.

  • Cash & Current Investments has increased in each of the last three years, with a five-year compound annual growth rate of 13.2% (FY2020 to FY2025).
  • Going back by year, Cash & Current Investments was $418.95 million in FY2024 (+22.6%), $341.63 million in FY2023 (+43.9%), $237.36 million in FY2022 (-27.4%) and $326.9 million in FY2021 (+6.9%).
  • The Q2 2026 figure represents the highest quarterly Cash & Current Investments in data going back to Q3 2015.
  • Year-over-year, Cash & Current Investments increased in seven of the last eight quarters, with growth averaging 29.9%.
  • The fastest year-over-year change in Cash & Current Investments over five years came in Q2 2024 (growth of 80.0%), and the weakest in Q4 2022 (a decline of 27.4%).
  • Business Quant data shows PTGX's Cash & Current Investments at $547.81 million (Q1 2026), $567.39 million (Q4 2025) and $576.12 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn 17.23 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn 6.57 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn 7.14 Bn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn 7.69 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn 4.90 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 3.18 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn 11.70 Bn
10 Protagonist Therapeutics 9.20 Bn 6.73 Bn - 782.58 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 782.58 Mn
Mar 31, 2026 547.81 Mn
Dec 31, 2025 567.39 Mn
Sep 30, 2025 576.12 Mn
Jun 30, 2025 570.47 Mn
Mar 31, 2025 574.36 Mn
Dec 31, 2024 418.95 Mn
Sep 30, 2024 468.72 Mn
Jun 30, 2024 564.04 Mn
Mar 31, 2024 322.67 Mn
Dec 31, 2023 341.63 Mn
Sep 30, 2023 320.75 Mn
Jun 30, 2023 313.40 Mn
Mar 31, 2023 230.79 Mn
Dec 31, 2022 237.36 Mn
Sep 30, 2022 267.44 Mn
Jun 30, 2022 291.94 Mn
Mar 31, 2022 305.29 Mn
Dec 31, 2021 326.90 Mn
Sep 30, 2021 314.34 Mn
API Access

Protagonist Therapeutics Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=PTGX&period=max&api_key=YOUR_API_KEY